Differential diagnostic considerations of EBV-positive DLBCL of the elderly
| Entity . | Site . | Architecture . | Immunophenotype . | Specific findings . | Light chain . | Clonality . |
|---|---|---|---|---|---|---|
| EBV-positive DLBCL, elderly | N (70%) | Effaced | Pan B markers+ | Geographic necrosis | Monotypic | Monoclonal |
| E (30%) | CD10−/BCL6−/MUM1+, EBER+,CD30+/− | |||||
| EBV-associated reactive atypical lymphoproliferations/infectious mononucleosis in elderly | N | Not effaced | Mixed B- and T-cell nature of HRS-like cells (CD3+/20+/30+) | n/a | Polytypic | Polyclonal |
| EBER+ | ||||||
| EBV-positive classical Hodgkin lymphoma | N | Effaced | CD20-/CD79a-/Pax5w+ | HRS cells in reactive background | Polytypic | Polyclonal |
| CD30+/CD15+, EBER+/− | ||||||
| DLBCL, NOS, anaplastic variant | N | Effaced | Pan B markers+ | Sinusodal or cohesive pattern | Monotypic | Monoclonal |
| EBER-, CD30+ | ||||||
| T-cell/histiocyte-rich large B-cell lymphoma | N | Effaced | Pan B markers+ | Scattered B cells in benign T cells/histiocytes background | Monotypic | Monoclonal |
| EBER−, CD30+/−, CD15- | ||||||
| Primary cutaneous DLBCL, leg type | E (skin) | Dermal infiltration | Pan B-cell markers+, EBER- | Diffuse sheets of centroblasts and immunoblasts | Monotypic | Monoclonal |
| BCL2+/MUM1+/FOXP1+ | ||||||
| Lymphomatoid granulomatosis | E | polymorphic infiltration | EBER+, LMP1− | Angioinvasion, HRS-like cells in reactive background | Noninformative | Monoclonal |
| Plasmablastic lymphoma of the elderly | N (50%) | Effaced | CD38+, CD138+, MUM1+, CD20− | Plasmablastic morphology | Monotypic | n/a |
| E (50%) | EBER+, LMP1−, EBNA2- | EBV latency I | ||||
| Angioimmunoblastic T-cell lymphoma | N | Effaced | CD10+, CXCL13+, PD1+ | FDC expansion | Polytypic | Monoclonal in T cells |
| Peripheral T-cell lymphoma, not otherwise specified | N | Effaced | CD3+/− with partial loss of T-markers, CD30+/−, CD15−/+ | Large atypical cells | Polytypic | Monoclonal in T cells |
| EBER−/+ | Clear cytoplasm+/− |
| Entity . | Site . | Architecture . | Immunophenotype . | Specific findings . | Light chain . | Clonality . |
|---|---|---|---|---|---|---|
| EBV-positive DLBCL, elderly | N (70%) | Effaced | Pan B markers+ | Geographic necrosis | Monotypic | Monoclonal |
| E (30%) | CD10−/BCL6−/MUM1+, EBER+,CD30+/− | |||||
| EBV-associated reactive atypical lymphoproliferations/infectious mononucleosis in elderly | N | Not effaced | Mixed B- and T-cell nature of HRS-like cells (CD3+/20+/30+) | n/a | Polytypic | Polyclonal |
| EBER+ | ||||||
| EBV-positive classical Hodgkin lymphoma | N | Effaced | CD20-/CD79a-/Pax5w+ | HRS cells in reactive background | Polytypic | Polyclonal |
| CD30+/CD15+, EBER+/− | ||||||
| DLBCL, NOS, anaplastic variant | N | Effaced | Pan B markers+ | Sinusodal or cohesive pattern | Monotypic | Monoclonal |
| EBER-, CD30+ | ||||||
| T-cell/histiocyte-rich large B-cell lymphoma | N | Effaced | Pan B markers+ | Scattered B cells in benign T cells/histiocytes background | Monotypic | Monoclonal |
| EBER−, CD30+/−, CD15- | ||||||
| Primary cutaneous DLBCL, leg type | E (skin) | Dermal infiltration | Pan B-cell markers+, EBER- | Diffuse sheets of centroblasts and immunoblasts | Monotypic | Monoclonal |
| BCL2+/MUM1+/FOXP1+ | ||||||
| Lymphomatoid granulomatosis | E | polymorphic infiltration | EBER+, LMP1− | Angioinvasion, HRS-like cells in reactive background | Noninformative | Monoclonal |
| Plasmablastic lymphoma of the elderly | N (50%) | Effaced | CD38+, CD138+, MUM1+, CD20− | Plasmablastic morphology | Monotypic | n/a |
| E (50%) | EBER+, LMP1−, EBNA2- | EBV latency I | ||||
| Angioimmunoblastic T-cell lymphoma | N | Effaced | CD10+, CXCL13+, PD1+ | FDC expansion | Polytypic | Monoclonal in T cells |
| Peripheral T-cell lymphoma, not otherwise specified | N | Effaced | CD3+/− with partial loss of T-markers, CD30+/−, CD15−/+ | Large atypical cells | Polytypic | Monoclonal in T cells |
| EBER−/+ | Clear cytoplasm+/− |
n/a, not available; FDC, follicular dendritic cell meshworks; Pan B-cell markers, CD19, CD20, CD22; Site E, extranodal; Site N, nodal.1,25,42-44,46,82,84-88